Diabetes drug Avandia raises the risk of heart attacks

Diabetes drug Avandia raises the risk of heart attacks
By: Associated Press

A new analysis links the widely prescribed diabetes drug Avandia to greater risk of heart attack and possibly death.
The analysis of dozens of studies revealed a 45% greater risk of heart attack. The results have been published online by the New England Journal of Medicine.
The drug is used to treat Type Two diabetes, the most common form of the disease, which is linked to obesity. It occurs when the body does not make enough insulin or cannot effectively use what it manages to produce.
Avandia helps sensitize the body to insulin and was considered a breakthrough medication for blood-sugar control.
Avandia is made by British-based GlaxoSmithKline.
(Copyright 2007 by The Associated Press. All Rights Reserved.)
----------------------------------------------

Drug maker defends Avandia, questions study
By: Associated Press

The makers of the diabetes drug Avandia are questioning an analysis linking the drug to an increased risk of heart attack.
The analysis of dozens of studies found a 45 percent greater risk of heart attack. The results are posted online by the New England Journal of Medicine.
More than 6-million people worldwide have taken the drug, sold by London-based GlaxoSmithKline. But Glaxo's chief of diabetes drug development says the study is not definitive scientific proof. He says the company is not seeing "anything like" the risks reported in the medical journal, and remains "very confident" in the drug's safety.
Avandia is used to treat Type Two diabetes, the most common form of the disease. It has been considered a breakthrough drug for blood-sugar control.
(Copyright 2007 by The Associated Press. All Rights Reserved.)